Covid Vaccine

New Delhi: With pharma giant AstraZeneca pausing the Oxford COVID-19 vaccine candidate's trials in other countries, the Serum Institute of India (SII) has been suspended by the Drugs…

Geneva: Since none of the candidate vaccines in advanced clinical trials so far has demonstrated a "clear signal" of efficacy at the level of at least 50% sought by the World Health…

Sydney: Holding out hope for its citizens, Australian Prime Minister Scott Morrison on Tuesday said the country has secured access to a "promising" potential coronavirus vaccine. What is…

Remdesivir has been launched under the brand name Remdac in the Indian market. Meant to treat patients suffering from severe symptoms of COVID-19, it will be priced at Rs 2,800 per 100 mg…

New Delhi: Phase I clinical trial of the COVID-19 vaccine candidate, ZyCoV-D of the drug firm Zydus Cadila has been completed and phase II of the clinical trials will commence from August 6.…

New Delhi: The Drugs Controller General of India (DCGI) has given green signal to Pune-based Serum Institute of India (SII) to conduct the phase 2 and 3 of clinical human trials of the…

The battle with coronavirus will not end at finding a vaccine alone. Yet another challenge will be the possibility of shortages of syringes, wipes, and protective gear needed for potential…

Bhubaneswar: COVID-19 vaccine will be available in the country tentatively by February next year, said director of the Institute of Life Sciences (ILS), Odisha branch, Ajay Parida on Monday.…

New Delhi: Among the legion efforts being made all over the world to develop a vaccine to contain the spread of coronavirus, are seven Indian pharma companies. Bharat Biotech, Serum…

New Delhi: Expressing immense confidence in India, Microsoft co-founder Bill Gates on Thursday said India's pharmaceutical industry will be able to produce COVID-19 vaccines not just for the…